Indications
Treatment of constipation. Evacuation of the bowel before
radiologic studies or surgery. Part of a bowel regimen
in spinal cord injury patients.
Action
Stimulates peristalsis. Alters fluid and electrolyte transport,
producing fluid accumulation in the colon. Therapeutic
Effects: Evacuation of the colon.
Pharmacokinetics
Absorption: Variable absorption follows oral administration;
rectal absorption is minimal; action is local in
the colon.
Distribution: Small amounts of metabolites excreted
in breast milk.
Metabolism and Excretion: Small amounts absorbed
are metabolized by the liver.
Half-life: Unknown.
TIME/ACTION PROFILE (evacuation of bowel)
ROUTE ONSET PEAK DURATION
PO 6–12 hr unknown unknown
Rectal 15–60 min unknown unknown
Contraindications/Precautions
Contraindicated in: Hypersensitivity; Abdominal
pain; Obstruction; Nausea or vomiting (especially with
fever or other signs of an acute abdomen).
Use Cautiously in: Severe cardiovascular disease;
Anal or rectal fissures; Excess or prolonged use (may
result in dependence); OB, Lactation: May be used during
pregnancy and lactation.
Adverse Reactions/Side Effects
GI: abdominal cramps, nausea, diarrhea, rectal burning.
F and E: hypokalemia (with chronic use). MS:
muscle weakness (with chronic use). Misc: proteinlosing
enteropathy, tetany (with chronic use).
Interactions
Drug-Drug: Antacids, histamine H2-receptor antagonists,
and gastric acid–pump inhibitors may
remove enteric coating of tablets resulting in gastric irritation/
dyspepsia. Maypthe absorption of other
orally administered drugs because ofqmotility and
ptransit time.
Drug-Food: Milk may remove enteric coating of tablets,
resulting in gastric irritation/dyspepsia.
Route/Dosage
PO (Adults and Children 12 yr): 5–15 mg/day
(up to 30 mg/day) as a single dose.
PO (Children 3–11 yr): 5–10 mg/day (0.3 mg/kg)
as a single dose.
Rect (Adults and Children 12 yr): 10 mg/day single
dose.
Rect (Children 2–11 yr): 5–10 mg/day single dose.
Rect (Children 2 yr): 5 mg/day single dose.
Availability (generic available)
Enteric-coated tablets: 5 mgOTC. Enteric coated
and delayed release: 5 mgOTC. Suppositories: 10
mgOTC. Rectal solution: 10 mg/30 mLOTC. In combination
with: In Bowel Preparation kits with Magnesium
citrate (Evac-Q-KwikOTC, EZ-EM Prep KitOTC,
LiquiPrep Bowel EvacuantOTC, Tridate Bowel Cleansing
KitOTC), Phosphate/biphosphate (Fleet Prep Kit. No.
1OTC, Fleet Prep Kit No. 2OTC, Fleet Prep Kit No. 3OTC),
sennosides (X-Prep Bowel Evacuant Kit #1OTC), sennosides,
magnesium citrate, magnesium sulfate (X-Prep
Bowel Evacuant Kit #2OTC). See Appendix B.
No comments:
Post a Comment